在患有囊性纤维化症的成年人中,使用呼吸阻力修改强制终止的技术
Kathryn Watson1,2, Emma Koenig1, Ashleigh Bannister1
1Physiotherapy Department, Sir Charles Gairdner Hospital, Perth, Australia.
The clinical respiratory journal
|October 4, 2023
概括
将呼吸阻力装置 (ERD) 添加到强制呼吸技术 (FET) 中没有改善囊性纤维化 (CF) 患者的粘液排泄. 然而,一些患者在没有ERD的情况下经历了更好的吐缓解 (EOE).
科学领域:
- 呼吸系统医学 呼吸系统医学
- 肺部病理学 肺部病理学
- 囊性纤维化研究 囊性纤维化研究
背景情况:
- 气道清除技术 (ACT) 对于治疗囊性纤维化 (CF) 和预防不可逆转的气道阻塞至关重要.
- 积极的呼吸压力 (PEP) 和呼吸阻力装置 (ERD) 通过改善附带通风和粘液剪切,有助于粘液清除.
- 这项研究调查了将ERD纳入CF患者的强迫到期技术 (FET) 的有效性.
研究的目的:
- 为了确定在FET期间使用ERD是否会提高CF患者的吐易度 (EOE),吐量和咳频率.
- 为了比较FET的有效性和没有ERD在空气通道清理的个人与CF.
主要方法:
- 经历呼吸道恶化的CF患者参与了这项研究.
- 每位患者完成了两次标准ACT,其中FET组件与ERD或单独执行.
- 收集的数据包括EOE,唾液湿重量和咳频率.
主要成果:
- 在带有ERD和没有ERD的FET之间,没有观察到EOE,唾液湿重或咳频率的显著差异.
- 通常使用PEP设备的参与者的一个子集在不使用ERD时报告了改善的EOE.
结论:
- 在这个小队列中,将FET与PEP口罩相结合并没有显著改善EOE或其他测量结果.
- 建议对更大的患者群体进行进一步的研究,以验证这些发现,并探索ERD辅助FET在CF气道清除中的有效性.
相关概念视频
Cystic Fibrosis: Management
177
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
177
Acute Respiratory Failure-III
197
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
197
Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Mechanism of Breathing II: Expiration
1.1K
The Physiology of Expiration: A Seamless Respiratory Process
Expiration, or exhaling, is a complex physiological process that begins as the inspiratory muscles begin to relax. This relaxation triggers a series of events that epitomize the efficiency of the respiratory system.
Mechanism of Expiration:
Expiration, or exhaling, is a complex physiological process that begins as the inspiratory muscles begin to relax. This relaxation triggers a series of events that epitomize the efficiency of the respiratory system.
Mechanism of Expiration:
1.1K
Mechanical Ventilation II: Invasive Ventilation
176
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
176
Acute Respiratory Failure-V
147
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
147


